ArticleThe Journal of biological chemistry2014

Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors.

Poorval M Joshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.